Cargando…
MiR-363 inhibits cisplatin chemoresistance of epithelial ovarian cancer by regulating snail-induced epithelial-mesenchymal transition
Chemoresistance is a major barrier to successful cisplatin-based chemotherapy for epithelial ovarian cancer (EOC), and emerging evidences suggest that microRNAs (miRNAs) are involved in the resistance. In this study, it was indicated that miR-363 downregulation was significantly correlated with EOC...
Autores principales: | Cao, Lanqin, Wan, Qian, Li, Fengjie, Tang, Can-e |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Biochemistry and Molecular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177509/ https://www.ncbi.nlm.nih.gov/pubmed/30037365 http://dx.doi.org/10.5483/BMBRep.2018.51.9.104 |
Ejemplares similares
-
NANOG regulates epithelial–mesenchymal transition and chemoresistance in ovarian cancer
por: Qin, Shan, et al.
Publicado: (2017) -
MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1
por: Zhang, Yongtao, et al.
Publicado: (2020) -
Exosome mediated miR-155 delivery confers cisplatin chemoresistance in oral cancer cells via epithelial-mesenchymal transition
por: Kirave, Prathibha, et al.
Publicado: (2020) -
FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells
por: Chiu, Wen-Tai, et al.
Publicado: (2014) -
Enhanced Epithelial-to-Mesenchymal Transition and Chemoresistance in Advanced Retinoblastoma Tumors Is Driven by miR-181a
por: Suresh Babu, Vishnu, et al.
Publicado: (2022)